Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Gabriele Endler has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP15002128

ORAL FORMULATION COMPRISING BERBERINE AND MORUS ALBA EXTRACT

IPC classification:
A61K 31/045, A61K 31/445, A61K 31/4745, A61K 31/519, A61K 36/062, A61K 36/29, A61K 36/60, A61P 3/04, A61P 3/06
Agent:
F. R. Kelly & Co.
Agent:
Gabriele Endler, MEDA Pharma GmbH & Co. KG
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature